Fourth quarter and full year 2018 results

Highlights

Sanofi delivers 2018 business EPS growth of 5.1% at CER

Fourth quarter and full year 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

In 2019 we will continue to build on the momentum achieved last year

Olivier Brandicourt

Chief Executive Officer

Results Infographic

Downloads

Download the audio mp3 file

Presentation

Clinical trials appendix

Press release – February 7, 2019: Sanofi delivers 2018 business EPS growth of 5.1% at CER

Q4 and full year 2018 income statements, cash flow statements, balance sheet

Q4 and full year 2018 net sales by GBU, franchise, geographic region and product

Download infographic

2018 sales reflecting the 2019 GBU structure